Optimal immunization strategies for Saanen goats against goatpox

Abstract Background Goatpox is a highly contagious disease caused by the Capripoxvirus, primarily affecting sheep and goats. Breeds like the Saanen are particularly vulnerable, especially in enzootic areas, and face risks not only from the disease itself but also from adverse reactions to live atten...

Full description

Saved in:
Bibliographic Details
Main Authors: Hossein Esmaeili, Seyed Mehdi Joghataei, Zeinab Hamidiya, Ehsan Baghal Arani, Amir pasha Shakeri, Zia Nosrat Rad, Mohammad Mahdi Safari
Format: Article
Language:English
Published: BMC 2025-05-01
Series:BMC Veterinary Research
Subjects:
Online Access:https://doi.org/10.1186/s12917-025-04783-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849311953911021568
author Hossein Esmaeili
Seyed Mehdi Joghataei
Zeinab Hamidiya
Ehsan Baghal Arani
Amir pasha Shakeri
Zia Nosrat Rad
Mohammad Mahdi Safari
author_facet Hossein Esmaeili
Seyed Mehdi Joghataei
Zeinab Hamidiya
Ehsan Baghal Arani
Amir pasha Shakeri
Zia Nosrat Rad
Mohammad Mahdi Safari
author_sort Hossein Esmaeili
collection DOAJ
description Abstract Background Goatpox is a highly contagious disease caused by the Capripoxvirus, primarily affecting sheep and goats. Breeds like the Saanen are particularly vulnerable, especially in enzootic areas, and face risks not only from the disease itself but also from adverse reactions to live attenuated vaccines. This study compares inactivated and attenuated vaccines to find the safest and most effective vaccination strategy for Saanen goats against the Goatpox Virus (GTPV). In this study, 375 pure-breed Saanen goats were strategically divided into four groups to explore the most effective vaccination protocols for combating combinations of vaccines. In contrast, one group remained unvaccinated as a control. After vaccination, the goats were challenged by exposure to naturally infected animals to assess the vaccines’ protective efficacy. PCR assays and the Virus Neutralization method were also conducted. Results Group G1 exhibited no adverse reactions following two inactivated vaccines, with only mild and brief signs observed in a small number of goats (2%) after the live attenuated vaccine. Group G2, which received an inactivated vaccine followed by a live attenuated vaccine, had mild lesions in 18.66% of the goats after vaccination. In contrast, Group G3, which only received the live attenuated vaccine, showed a high morbidity rate of 82% and a mortality rate of 22%, with severe clinical signs and Pox lesions. Following the challenge, no signs of GTPV infection were observed in Groups G1, G2, and G3, whereas the control group exhibited 100% morbidity and 72% mortality, confirming the vaccine’s protective efficacy. Conclusion This study found that a protocol using two inactivated vaccine doses at one-month intervals, followed by a live attenuated vaccine and annual boosters, effectively immunizes vulnerable breeds against GTPV without causing adverse reactions. This approach prevents complications and supports breeding in GTPV-enzootic regions.
format Article
id doaj-art-6dba134047f54d85b189da44f7531e29
institution Kabale University
issn 1746-6148
language English
publishDate 2025-05-01
publisher BMC
record_format Article
series BMC Veterinary Research
spelling doaj-art-6dba134047f54d85b189da44f7531e292025-08-20T03:53:13ZengBMCBMC Veterinary Research1746-61482025-05-0121111210.1186/s12917-025-04783-zOptimal immunization strategies for Saanen goats against goatpoxHossein Esmaeili0Seyed Mehdi Joghataei1Zeinab Hamidiya2Ehsan Baghal Arani3Amir pasha Shakeri4Zia Nosrat Rad5Mohammad Mahdi Safari6Department of Microbiology and Immunology, Faculty of Veterinary Medicine, University of TehranDepartment of Microbiology and Immunology, Faculty of Veterinary Medicine, University of TehranDepartment of Basic Sciences, Faculty of Veterinary Medicine, University of TehranDepartment of Microbiology and Immunology, Faculty of Veterinary Medicine, University of TehranDepartment of Microbiology and Immunology, Faculty of Veterinary Medicine, University of TehranDepartment of Microbiology and Immunology, Faculty of Veterinary Medicine, University of TehranDepartment of Microbiology and Immunology, Faculty of Veterinary Medicine, University of TehranAbstract Background Goatpox is a highly contagious disease caused by the Capripoxvirus, primarily affecting sheep and goats. Breeds like the Saanen are particularly vulnerable, especially in enzootic areas, and face risks not only from the disease itself but also from adverse reactions to live attenuated vaccines. This study compares inactivated and attenuated vaccines to find the safest and most effective vaccination strategy for Saanen goats against the Goatpox Virus (GTPV). In this study, 375 pure-breed Saanen goats were strategically divided into four groups to explore the most effective vaccination protocols for combating combinations of vaccines. In contrast, one group remained unvaccinated as a control. After vaccination, the goats were challenged by exposure to naturally infected animals to assess the vaccines’ protective efficacy. PCR assays and the Virus Neutralization method were also conducted. Results Group G1 exhibited no adverse reactions following two inactivated vaccines, with only mild and brief signs observed in a small number of goats (2%) after the live attenuated vaccine. Group G2, which received an inactivated vaccine followed by a live attenuated vaccine, had mild lesions in 18.66% of the goats after vaccination. In contrast, Group G3, which only received the live attenuated vaccine, showed a high morbidity rate of 82% and a mortality rate of 22%, with severe clinical signs and Pox lesions. Following the challenge, no signs of GTPV infection were observed in Groups G1, G2, and G3, whereas the control group exhibited 100% morbidity and 72% mortality, confirming the vaccine’s protective efficacy. Conclusion This study found that a protocol using two inactivated vaccine doses at one-month intervals, followed by a live attenuated vaccine and annual boosters, effectively immunizes vulnerable breeds against GTPV without causing adverse reactions. This approach prevents complications and supports breeding in GTPV-enzootic regions.https://doi.org/10.1186/s12917-025-04783-zSaanenGoatsGoatpoxVaccinationPox lesionsLive attenuated goatpox vaccine
spellingShingle Hossein Esmaeili
Seyed Mehdi Joghataei
Zeinab Hamidiya
Ehsan Baghal Arani
Amir pasha Shakeri
Zia Nosrat Rad
Mohammad Mahdi Safari
Optimal immunization strategies for Saanen goats against goatpox
BMC Veterinary Research
Saanen
Goats
Goatpox
Vaccination
Pox lesions
Live attenuated goatpox vaccine
title Optimal immunization strategies for Saanen goats against goatpox
title_full Optimal immunization strategies for Saanen goats against goatpox
title_fullStr Optimal immunization strategies for Saanen goats against goatpox
title_full_unstemmed Optimal immunization strategies for Saanen goats against goatpox
title_short Optimal immunization strategies for Saanen goats against goatpox
title_sort optimal immunization strategies for saanen goats against goatpox
topic Saanen
Goats
Goatpox
Vaccination
Pox lesions
Live attenuated goatpox vaccine
url https://doi.org/10.1186/s12917-025-04783-z
work_keys_str_mv AT hosseinesmaeili optimalimmunizationstrategiesforsaanengoatsagainstgoatpox
AT seyedmehdijoghataei optimalimmunizationstrategiesforsaanengoatsagainstgoatpox
AT zeinabhamidiya optimalimmunizationstrategiesforsaanengoatsagainstgoatpox
AT ehsanbaghalarani optimalimmunizationstrategiesforsaanengoatsagainstgoatpox
AT amirpashashakeri optimalimmunizationstrategiesforsaanengoatsagainstgoatpox
AT zianosratrad optimalimmunizationstrategiesforsaanengoatsagainstgoatpox
AT mohammadmahdisafari optimalimmunizationstrategiesforsaanengoatsagainstgoatpox